Suppr超能文献

使用真正的再入装置进行内膜下血管成形术治疗下肢动脉慢性完全闭塞。

Subintimal angioplasty with a true reentry device for treatment of chronic total occlusion of the arteries of the lower extremity.

机构信息

Aurora Cardiovascular Services, Aurora Sinai/Aurora St. Luke's Medical Centers, University of Wisconsin School of Medicine and Public Health, Milwaukee, Wisconsin.

出版信息

Catheter Cardiovasc Interv. 2013 Nov 1;82(5):701-6. doi: 10.1002/ccd.22743. Epub 2013 Mar 28.

Abstract

OBJECTIVE

To report the efficacy and safety of the Outback(®) LTD(®) Re-Entry Catheter in reentering the distal true lumen during percutaneous intentional extraluminal revascularization (PIER).

BACKGROUND

Reentry catheters are used to treat chronic, total arterial occlusions of the lower extremities when standard methods of recanalization have failed. Success and complication rates of these catheters in the real world are uncertain and variable.

METHODS

A retrospective review of our peripheral catheterization database from January 2004 to September 2009 was undertaken to identify consecutive cases of peripheral chronic total occlusions (CTOs) requiring the use of the Outback reentry catheter. Patient demographics, indication for the procedure, location and extent of occlusion, procedural success, and complications were studied.

RESULTS

A total of 51 patients were identified. Of the 51, 28 (54.9%) patients presented with nonhealing ulcer and 22 (43.1%) had lifestyle-limiting claudication. One patient presented with acute limb ischemia. There were 6 (11.8%) patients with common iliac artery occlusion, 2 (3.9%) with external iliac artery occlusion, 1 (1.9%) with common femoral artery occlusion, 35 (68.6%) with superficial femoral artery occlusion, 6 (11.8%) with popliteal artery occlusion, and 1 (1.9%) with tibioperoneal artery occlusion. Median lesion length was 230 mm. Procedural success was achieved in 49 patients (96.1%). There was 1 (1.9%) periprocedural complication.

CONCLUSION

Use of Outback(®) LTD(®) Re-Entry Catheter is a safe and valuable option for PIER/subintimal angioplasty and recanalization in patients with symptomatic lower-extremity CTOs. However, long-term patency remains unknown.

摘要

目的

报告 Outback(®) LTD(®) 再入导管在经皮腔内意向外血管重建(PIER)中重新进入远端真腔的疗效和安全性。

背景

再入导管用于治疗下肢慢性完全性动脉闭塞,当标准再通方法失败时。这些导管在真实世界中的成功率和并发症率不确定且多变。

方法

回顾性分析 2004 年 1 月至 2009 年 9 月我们的外周导管数据库,以确定需要使用 Outback 再入导管的连续外周慢性完全闭塞(CTO)病例。研究了患者的人口统计学特征、手术适应证、闭塞部位和程度、手术成功率和并发症。

结果

共确定了 51 例患者。51 例患者中,28 例(54.9%)患者出现溃疡不愈合,22 例(43.1%)患者出现生活受限性跛行。1 例患者出现急性肢体缺血。有 6 例(11.8%)患者髂总动脉闭塞,2 例(3.9%)髂外动脉闭塞,1 例(1.9%)股总动脉闭塞,35 例(68.6%)股浅动脉闭塞,6 例(11.8%)腘动脉闭塞,1 例(1.9%)胫前胫后动脉闭塞。中位病变长度为 230mm。49 例患者(96.1%)手术成功。有 1 例(1.9%)围手术期并发症。

结论

在有症状的下肢 CTO 患者中,使用 Outback(®) LTD(®) 再入导管进行 PIER/内膜下血管成形术和再通是一种安全且有价值的选择。然而,长期通畅性尚不清楚。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验